Daniel Nava Rodrigues
- Pulmonary and Respiratory Medicine top 2%
- Molecular Biology top 10%
- Oncology top 5%
- Cancer Research top 2%
- Genetics top 10%
- Co-authors
- Johann S. de BonoJorge S. Reis‐FilhoJoaquı́n MateoDavid LorenteBritta WeigeltSuzanne CarreiraRuth RiisnaesNina Tunariu
- Topics
- Prostate Cancer Treatment and Research (23 papers)Cancer Genomics and Diagnostics (11 papers)Cancer, Lipids, and Metabolism (8 papers)
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
Daniel Nava Rodrigues
51 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 98
- Pulmonary and Respiratory Medicine 1.0k
- Molecular Biology 948
- Oncology 878
- Cancer Research 820
- Genetics 208
Countries citing papers authored by Daniel Nava Rodrigues
This map shows the geographic impact of Daniel Nava Rodrigues's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Nava Rodrigues with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Nava Rodrigues more than expected).
Fields of papers citing papers by Daniel Nava Rodrigues
This network shows the impact of papers produced by Daniel Nava Rodrigues. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Nava Rodrigues. The network helps show where Daniel Nava Rodrigues may publish in the future.
Co-authorship network of co-authors of Daniel Nava Rodrigues
This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Nava Rodrigues. A scholar is included among the top collaborators of Daniel Nava Rodrigues based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Nava Rodrigues. Daniel Nava Rodrigues is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 19 | |
| 4 | 62 | |
| 5 | 11 | |
| 6 | 227 | |
| 7 | 44 | |
| 8 | 30 | |
| 9 | 27 | |
| 10 | 66 | |
| 11 | 70 | |
| 12 | 3 | |
| 13 | 40 | |
| 14 | 53 | |
| 15 | 23 | |
| 16 | 7 | |
| 17 | 108 | |
| 18 | 54 | |
| 19 | 40 | |
| 20 | 14 |
About Daniel Nava Rodrigues
Daniel Nava Rodrigues is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 54 papers that have together received 2.2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (23 papers), Cancer Genomics and Diagnostics (11 papers) and Cancer, Lipids, and Metabolism (8 papers). The work is most often cited by research in Cancer Research (820 citations), Oncology (878 citations) and Pulmonary and Respiratory Medicine (1.0k citations). Daniel Nava Rodrigues has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Johann S. de Bono, Jorge S. Reis‐Filho, Joaquı́n Mateo, David Lorente, Britta Weigelt, Suzanne Carreira, Ruth Riisnaes, Nina Tunariu, Susana Miranda and Gerhardt Attard. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.